Sharna D Jamadar1,2,3, Emma X Liang1, Shenjun Zhong1,4, Phillip G D Ward1,3, Alexandra Carey1,5, Richard McIntyre1,5, Zhaolin Chen1,6, Gary F Egan1,2,3. 1. Monash Biomedical Imaging, Monash University, Melbourne, VIC 3800, Australia. 2. Turner Institute for Brain and Mental Health, Monash University, Melbourne, VIC 3800, Australia. 3. Australian Research Council Centre of Excellence for Integrative Brain Function, 3800 Australia. 4. National Imaging Facility, 4072, Australia. 5. Department of Medical Imaging, Monash Health, VIC 3800, Australia. 6. Monash Data Futures Institute, Monash University , Melbourne, VIC 3800, Australia.
Abstract
BACKGROUND: "Functional" [18F]-fluorodeoxyglucose positron emission tomography (FDG-fPET) is a new approach for measuring glucose uptake in the human brain. The goal of FDG-fPET is to maintain a constant plasma supply of radioactive FDG in order to track, with high temporal resolution, the dynamic uptake of glucose during neuronal activity that occurs in response to a task or at rest. FDG-fPET has most often been applied in simultaneous BOLD-fMRI/FDG-fPET (blood oxygenation level-dependent functional MRI fluorodeoxyglucose functional positron emission tomography) imaging. BOLD-fMRI/FDG-fPET provides the capability to image the 2 primary sources of energetic dynamics in the brain, the cerebrovascular haemodynamic response and cerebral glucose uptake. FINDINGS: In this Data Note, we describe an open access dataset, Monash DaCRA fPET-fMRI, which contrasts 3 radiotracer administration protocols for FDG-fPET: bolus, constant infusion, and hybrid bolus/infusion. Participants (n = 5 in each group) were randomly assigned to each radiotracer administration protocol and underwent simultaneous BOLD-fMRI/FDG-fPET scanning while viewing a flickering checkerboard. The bolus group received the full FDG dose in a standard bolus administration, the infusion group received the full FDG dose as a slow infusion over the duration of the scan, and the bolus-infusion group received 50% of the FDG dose as bolus and 50% as constant infusion. We validate the dataset by contrasting plasma radioactivity, grey matter mean uptake, and task-related activity in the visual cortex. CONCLUSIONS: The Monash DaCRA fPET-fMRI dataset provides significant reuse value for researchers interested in the comparison of signal dynamics in fPET, and its relationship with fMRI task-evoked activity.
BACKGROUND: "Functional" [18F]-fluorodeoxyglucose positron emission tomography (FDG-fPET) is a new approach for measuring glucose uptake in the human brain. The goal of FDG-fPET is to maintain a constant plasma supply of radioactive FDG in order to track, with high temporal resolution, the dynamic uptake of glucose during neuronal activity that occurs in response to a task or at rest. FDG-fPET has most often been applied in simultaneous BOLD-fMRI/FDG-fPET (blood oxygenation level-dependent functional MRI fluorodeoxyglucose functional positron emission tomography) imaging. BOLD-fMRI/FDG-fPET provides the capability to image the 2 primary sources of energetic dynamics in the brain, the cerebrovascular haemodynamic response and cerebral glucose uptake. FINDINGS: In this Data Note, we describe an open access dataset, Monash DaCRA fPET-fMRI, which contrasts 3 radiotracer administration protocols for FDG-fPET: bolus, constant infusion, and hybrid bolus/infusion. Participants (n = 5 in each group) were randomly assigned to each radiotracer administration protocol and underwent simultaneous BOLD-fMRI/FDG-fPET scanning while viewing a flickering checkerboard. The bolus group received the full FDG dose in a standard bolus administration, the infusion group received the full FDG dose as a slow infusion over the duration of the scan, and the bolus-infusion group received 50% of the FDG dose as bolus and 50% as constant infusion. We validate the dataset by contrasting plasma radioactivity, grey matter mean uptake, and task-related activity in the visual cortex. CONCLUSIONS: The Monash DaCRA fPET-fMRI dataset provides significant reuse value for researchers interested in the comparison of signal dynamics in fPET, and its relationship with fMRI task-evoked activity.
Authors: Mark Oehmigen; Susanne Ziegler; Bjoern W Jakoby; Jens-Christoph Georgi; Daniel H Paulus; Harald H Quick Journal: J Nucl Med Date: 2014-07-08 Impact factor: 10.057
Authors: Marjorie Villien; Hsiao-Ying Wey; Joseph B Mandeville; Ciprian Catana; Jonathan R Polimeni; Christin Y Sander; Nicole R Zürcher; Daniel B Chonde; Joanna S Fowler; Bruce R Rosen; Jacob M Hooker Journal: Neuroimage Date: 2014-06-14 Impact factor: 6.556
Authors: Mark Jenkinson; Christian F Beckmann; Timothy E J Behrens; Mark W Woolrich; Stephen M Smith Journal: Neuroimage Date: 2011-09-16 Impact factor: 6.556
Authors: Ninon Burgos; M Jorge Cardoso; Kris Thielemans; Marc Modat; Stefano Pedemonte; John Dickson; Anna Barnes; Rebekah Ahmed; Colin J Mahoney; Jonathan M Schott; John S Duncan; David Atkinson; Simon R Arridge; Brian F Hutton; Sebastien Ourselin Journal: IEEE Trans Med Imaging Date: 2014-07-17 Impact factor: 10.048
Authors: Sandeep S V Golla; Mark Lubberink; Bart N M van Berckel; Adriaan A Lammertsma; Ronald Boellaard Journal: EJNMMI Res Date: 2017-04-21 Impact factor: 3.138
Authors: Andreas Hahn; Michael Breakspear; Lucas Rischka; Wolfgang Wadsak; Godber M Godbersen; Verena Pichler; Paul Michenthaler; Thomas Vanicek; Marcus Hacker; Siegfried Kasper; Rupert Lanzenberger; Luca Cocchi Journal: Elife Date: 2020-04-21 Impact factor: 8.713
Authors: Lucas Rischka; Godber M Godbersen; Verena Pichler; Paul Michenthaler; Sebastian Klug; Manfred Klöbl; Vera Ritter; Wolfgang Wadsak; Marcus Hacker; Siegfried Kasper; Rupert Lanzenberger; Andreas Hahn Journal: J Cereb Blood Flow Metab Date: 2021-06-02 Impact factor: 6.200